OncologyTube Professional - Patients Click Here
255,580 video views
VJOncology: Videos
01:02
To improve the efficacy of immunotherapy in patients with glioblastoma (GBM), the mechanisms behind the phenomenon of why bone marrow T-cell sequestration occurs in these patients needs to be understood. Here, Pakawat Chongsathidkiet, MD, of Duke University, Durham, NC, discusses the techniques bein...
by:VJOncology | 21 views
01:10
Glioblastoma (GBM) is a common and aggressive cancer that starts within the brain. So far, patients with GBM who undergo immunotherapy are not responding well to the treatment and poor outcomes remain. Here, speaking at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool...
by:VJOncology | 154 views
01:27
Genetic testing is not always routinely available to breast and/or ovarian cancer patients, or those at high-risk of developing these malignancies; the question is, why? And how can these challenges be tackled? Speaking at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverp...
by:VJOncology | 17 views
01:15
Due to advancements in genetic testing, women who have breast and/or ovarian cancer, or who are at high-risk of developing these cancers, are easier to identify. Genetic testing can also lead to the identification of any relatives who have mutations in the genes responsible for the development of br...
by:VJOncology | 13 views
01:48
The 2018 Annual Hematology/Onco​logy Pharmacy Association (HOPA) Conference, held in Denver, CO, saw many thought-provoki​ng sessions and exciting updates. Here, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Center, Minneapolis, MN, provides an overview of his presentation...
by:VJOncology | 15 views
01:28
Here, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Center, Minneapolis, MN, gives an insight into his experience of the 2018 Hematology/Onco​logy Pharmacy Association (HOPA) Annual Conference, held in Denver, CO. Dr Hanna also offers an insightful perspective into the be...
by:VJOncology | 12 views
03:49
Speaking from the 2018 Hematology/Onco​logy Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Center, Minneapolis, MN, offers his recommendations, for colleagues in the field, on the treatment options availabl...
by:VJOncology | 8 views
02:11
The future is looking bright for bladder cancer, with many clinical studies of new therapeutic options underway. Speaking from the 2018 Hematology/Onco​logy Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Ce...
by:VJOncology | 13 views
03:44
New and exciting developments on urothelial cancer were presented at the 2018 Hematology/Onco​logy Pharmacy Association (HOPA) Annual Conference, held in Denver, CO. In this detailed interview, Kirollos Hanna, PharmD, BCOP, BCPS of the University of Minnesota Medical Center, Minneapolis, MN, discusse...
by:VJOncology | 10 views
03:13
At the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, we asked a range of experts what they thought the key unanswered question in lung cancer is currently. They were all in agreement that there are a range of issues to address, but each speaker had their own...
by:VJOncology | 9 views
dsfsd